Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
DexCom, Inc. - Common Stock
(NQ:
DXCM
)
88.78
-0.56 (-0.63%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 21, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about DexCom, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
2 Growth Stocks to Buy at a Discount
August 18, 2024
Look beyond share price at the business behind the stock, and you might find there's more for investors to consider.
Via
The Motley Fool
Large-Cap Stocks In Trouble: Here Are The 10 Worst Performers
August 17, 2024
Over the past twelve months, 10 large-cap stocks have underperformed all others. Here’s this week’s list of the top 10 worst performing large-caps.
Via
Talk Markets
S&P 500, Nasdaq 100 Mark Seventh Straight Positive Session, Strongest Week Since October 2023: Friday's Top Movers
August 16, 2024
S&P 500 and Nasdaq 100 indices gain for seventh straight day, marking best weekly performance since October 2023 on positive economic data. SPY and QQQ close with modest daily gains while DIA has best...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
1 Growth Stock Down 43% to Buy Right Now
August 16, 2024
Here's why DexCom should be on your radar after the company's share price plunged recently.
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
August 15, 2024
Via
Benzinga
Here's How Much You Would Have Made Owning DexCom Stock In The Last 15 Years
August 05, 2024
Via
Benzinga
Demystifying DexCom: Insights From 15 Analyst Reviews
July 29, 2024
Via
Benzinga
Top 3 Stocks to Watch: Options Traders Bet on Big Gains
August 13, 2024
Three stocks have stood out for call option traders to bet on in the coming months as a view for a recovery rally after an S&P 500 sell-off last week
Via
MarketBeat
Topics
Stocks
Exposures
US Equities
Should You Buy the 3 Worst Nasdaq 100 Stocks Since the Tech Sector Selloff?
August 12, 2024
The tech sector began selling off in July as investors abandoned former higher fliers, leaving these three as the worst Nasdaq 100 stocks.
Via
InvestorPlace
DexCom, Inc. (DXCM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
August 09, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Should You Buy DexCom Stock After Its Post-Earnings Sell-Off?
August 08, 2024
DexCom now trades at a drastically lower earnings multiple than it has in the past.
Via
The Motley Fool
Jim Cramer: This Energy Stock Is A Buy, Stay Away From DexCom
August 08, 2024
The "Mad Money" host says Dexcom had "a real bad miss... they still really haven't fully explained why that is."
Via
Benzinga
These Stocks Just Dropped by 40% and 15% -- Should You Buy the Dip?
August 08, 2024
It might be a great time to buy low.
Via
The Motley Fool
Chips, Glorious Chips!
August 07, 2024
Someone's gotta make 'em, and someone's gotta buy 'em.
Via
The Motley Fool
Is It Time to Buy July's Worst-Performing Nasdaq Stocks?
August 07, 2024
These three Nasdaq stocks saw price drops of more than 35% last month. Are they good buys or too risky to touch today?
Via
The Motley Fool
Hims & Hers Reports Stellar Quarter: Stock Set for a Rally
August 06, 2024
Hims & Hers stock is showing the market why its fair value is double-digits above where it trades today, with Wall Street analysts to agree
Via
MarketBeat
Topics
Bonds
ETFs
Exposures
Debt Markets
Down 40% in 1 Day, Is DexCom Stock Still a Buy?
August 06, 2024
Competition and new growth headwinds could derail the stock even further.
Via
The Motley Fool
Bragar Eagel & Squire, P.C. Is Investigating Nano Nuclear, Iris Energy, Ford, and DexCom and Encourages Investors to Contact the Firm
August 05, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of DexCom, Inc. (DXCM) on Behalf of Investors
August 05, 2024
From
Law Offices of Howard G. Smith
Via
Business Wire
DoorDash And Exact Sciences Are Among Top 10 Large Cap Gainers Last Week (July 28-Aug 3): Are The Others In Your Portfolio?
August 04, 2024
Top 10 stocks with highest gains last week, including Exact Sciences, Alnylam Pharmaceuticals, Resmed, Coca-Cola Consolidated, DexCom, Sprouts Farmers Market, UL Solutions, Labcorp Holdings, C.H....
Via
Benzinga
Hims & Hers Stock Falls on DexCom Fears: Analysts Predict Rally
August 03, 2024
Hims & Hers stock is looking like a worthy dip to watch in the coming months, especially as its decline had nothing to do with company operations
Via
MarketBeat
The Law Offices of Frank R. Cruz Announces Investigation of DexCom, Inc. (DXCM) on Behalf of Investors
August 02, 2024
From
The Law Offices of Frank R. Cruz
Via
Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of DexCom, Inc. (DXCM) on Behalf of Investors
August 02, 2024
From
Glancy Prongay & Murray LLP
Via
Business Wire
As Diabetes Battle Heats Up, Spotlight Turns To Dexcom, Abbott
August 02, 2024
Dexcom is taking on bigger rival Abbott Laboratories with a continuous glucose monitor for non insulin users.
Via
Investor's Business Daily
DexCom, Inc. (DXCM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
August 01, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Jim Cramer Says This Home Improvement Chain Is A Buy Ahead Of Fed Rate Cut Cycle: 'I Would Pick Some Up Tomorrow'
July 31, 2024
Jim Cramer recommends buying Blackstone Inc. (BX) due to its strong companies and expects Lowe's (LOW) stock to benefit from Federal Reserve's rate cut.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Top 3 Health Care Stocks That May Explode In Q3
July 31, 2024
Via
Benzinga
NASDAQ: DXCM Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages DexCom, Inc. (NASDAQ: DXCM) Investors with Significant Losses to Contact the Firm
July 30, 2024
From
Kessler Topaz Meltzer & Check, LLP
Via
Business Wire
Market Momentum: Your Weekly Financial Forecast
July 30, 2024
Originally published at VolumeLeaders What to expect for July 29- August 02, 2024
Via
Benzinga
DexCom Stock Plunged Over 40% Last Week. Are Eli Lilly's and Novo Nordisk's Drugs to Blame?
July 30, 2024
DexCom faces several challenges, but GLP-1 drugs aren't big problems for the company right now.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.